Can MDMA-AT Be Saved?: Part I

"This is Why We Can't Have Nice Things"

Welcome to The Frontier Psychiatrists. The FDA held an advisory committee meeting aired on YouTube (link here), and it included the study sponsor (Lykos Theraputics, formerly MAPS PBC) presenting the data from their clinical trials. I know and respect some of the more recently hired folks at Lykos, and they were a sponsor for our Rapid Acting Mental Health Treatment (RAMHT) event here in NYC just a few weeks back.

The coverage of yesterday’s advisory committee hearing by Psychedelic Alpha was, by the way, awesome.

This series of articles? It is not intended as a hit piece. It is going to include reporting on what transpired yesterday, leading to two votes from the advisory committee against the approval of MDMA-AT as a treatment for Post-Traumatic Stress Disorder (PTSD).

I write this as someone with no vested interest in this specific modality being a “winner.” However, I do have a very keen interest in more effective treatments. I believe MDMA, Ibogaine, Psilocybin, and other p…